CD19 and B-cell chronic lymphocytic leukemia: Originally described as a T-cell marker, CD5 is also expressed on a subset of ‘innate’ (B1) B cells and on CLL cells where, together with CD19+, CD20low, CD23+, CD79low, and either kappa or lambda IG light chains, they constitute diagnostic criteria [19].